| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-06 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-06 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.21 | 8e-06 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.14 | 1e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 4e-05 |